Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ADVM will rise by +0.19% over the next 2 Weeks and hit $4.37 by Tuesday, December 23, 2025. In that time frame, ADVM's share price is expected to range between $4.29 and $4.45.
BearishAverageBullishADVM shares remained flat 0 in Tuesday, December 9, 2025's trading session, starting and closing at a previous close of $4.36 to move at $4.36. The stock demonstrated notable intraday movement (see ADVM's key stats for a full breakdown), fluctuating between $4.24 and $4.36, a +2.83% trading range. While recent weeks have seen some volatility, ADVM has managed to secure a +6.60% gain over the past 2 weeks. The neutral price movement was accompanied by decreased trading volume, with approximately 675.98K shares changing hands, 291.94K fewer than the previous session. This amounted to $2.95M in total market activity.
Will ADVM Continue Its Upward Trend?
According to analyst ratings and projections for ADVM, Adverum Biotechnologies, Inc. shares are anticipated to increase by +5.20%, potentially reaching $4.60 per share by December 23, 2025. Short-term technical indicators currently suggest a neutral sentiment for ADVM. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the ADVM stock forecast, now is a good time to buy ADVM stock because its current trading price is -3.35% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on ADVM covering social and institutional perspectives.
ADVM Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ADVM's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 55.48% to 66.74%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 54.04%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.94%, maintains a neutral outlook for the long term. Insights into ADVM's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Adverum Biotechnologies Short-Term Forecasts
ADVM Forecast For Next 5 Days
Our algorithm anticipates Adverum Biotechnologies (ADVM) stock could hit $4.24 by Dec 30, 2025. This represents a -2.67% rise from today's price, following a +4.81% change over the past five days.
ADVM Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Adverum Biotechnologies, Inc. (ADVM) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $4.24, which would mean a -2.75% decrease from the current price of $4.36. Projections for this period range from a high of $4.96 to a low of $3.58.
ADVM Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Adverum Biotechnologies's price over the next three months point to a rise. ADVM stock is expected to peak at $12.01 on Feb 25, 2026 after potentially dipping to $5.79 on Jan 09, 2026. On average, ADVM is likely to trade around $8.85 in the coming 90 days.
Adverum Biotechnologies Stock Forecast 2025
Based on our predictive models, Adverum Biotechnologies (ADVM) is expected to trade between $6.17 and $7.61 throughout 2025. This would result in an average price of $6.88, potentially offering investors a +57.80% return from current levels.
Adverum Biotechnologies, Inc. Monthly Forecast 2025–2026
December 2025
According to our latest forecast models, Adverum Biotechnologies, Inc. (ADVM) is positioned to show a strong performance in December 2025. The price is predicted to move between $6.17 and $7.61, settling at an average of $6.88. This could translate to a +57.80% gain.
January 2026
Based on current market signals, Adverum Biotechnologies, Inc. is projected to trend january 2026. We forecast a trading range from $5.79 to $8.46, with a likely average price of $6.92. Investors could expect a potential return of +58.72%.
February 2026
Our predictive algorithms indicate Adverum Biotechnologies, Inc. stock may see a shift in February 2026. The expected range spans $8.10–$12.01, with an average target of $10.43. This represents a positive outlook and a possible gain of +139.22%.
March 2026
Analyzing established trends, Adverum Biotechnologies, Inc. looks set to move in March 2026. Projections place the stock between $5.79 and $11.64, averaging around $9.84. This suggests a +125.69% gain from current levels.
April 2026
Market indicators suggest Adverum Biotechnologies, Inc. could experience notable changes during April 2026. Prices could fluctuate within $4.18 to $7.89, with a midpoint forecast of $6.92. The stock might deliver a +58.72% gain.
May 2026
Forecasting for May 2026, models estimate that Adverum Biotechnologies, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $2.53 and $7.29, averaging $6.71. This signals a positive trajectory with potential returns around +53.90%.
June 2026
According to our latest forecast models, Adverum Biotechnologies, Inc. (ADVM) is positioned to show a strong performance in June 2026. The price is predicted to move between $1.14 and $7.55, settling at an average of $7.38. This could translate to a +69.27% gain.
July 2026
Based on current market signals, Adverum Biotechnologies, Inc. is projected to trend july 2026. We forecast a trading range from $0.00 to $10.14, with a likely average price of $8.71. Investors could expect a potential return of +99.77%.
August 2026
Our predictive algorithms indicate Adverum Biotechnologies, Inc. stock may see a shift in August 2026. The expected range spans $0.00–$9.45, with an average target of $8.74. This represents a positive outlook and a possible gain of +100.46%.
September 2026
Analyzing established trends, Adverum Biotechnologies, Inc. looks set to move in September 2026. Projections place the stock between $0.00 and $12.36, averaging around $9.51. This suggests a +118.12% gain from current levels.
October 2026
Market indicators suggest Adverum Biotechnologies, Inc. could experience notable changes during October 2026. Prices could fluctuate within $0.00 to $15.54, with a midpoint forecast of $11.06. The stock might deliver a +153.67% gain.
November 2026
Forecasting for November 2026, models estimate that Adverum Biotechnologies, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $16.10, averaging $10.80. This signals a positive trajectory with potential returns around +147.71%.
December 2026
According to our latest forecast models, Adverum Biotechnologies, Inc. (ADVM) is positioned to show a strong performance in December 2026. The price is predicted to move between $0.00 and $15.05, settling at an average of $9.86. This could translate to a +126.15% gain.
ADVM's history of dividends and stock splits also plays a role in long-term investor confidence.

